ReviewNutrients2026
Coffee and Physical Performance: What Is Driven by Caffeine and What Is Not.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coffee is widely consumed by physically active individuals and athletes, often with the intention of enhancing alertness, reducing fatigue and supporting exercise performance. Its performance-related effects are primarily attributed to caffeine; however, responses to coffee consumption vary substantially across individuals and type of training. This narrative review examines current evidence on the role of coffee consumption in sport, with particular emphasis on caffeine-related mechanisms, physical performance, fatigue, muscle pain and recovery, as well as factors modifying individual responses, including circadian rhythm, habitual intake and genetic variability. Available evidence indicates that coffee consumption prior to physical activity may support endurance performance, reduce perceived exertion and attenuate muscle pain, particularly during prolonged or demanding exercise and under conditions of sleep restriction or circadian misalignment. In contrast, effects on muscle strength and power performance appear less consistent and more context dependent. Interindividual differences in caffeine metabolism, sensitivity to stimulation and susceptibility to sleep disruption further influence both the effectiveness and tolerability of coffee intake. Emerging findings also suggest that coffee, when consumed in combination with carbohydrates, may enhance post-exercise muscle glycogen resynthesis, a potential benefit of particular relevance for endurance athletes facing limited recovery time. At the same time, evidence regarding non-caffeine bioactive compounds present in coffee remains limited and largely indirect, indicating a modulatory rather than ergogenic role. Overall, coffee should not be regarded as a universally effective ergogenic aid, as its effects may vary according to individual characteristics, training demands and the timing of consumption. Its effective use requires careful consideration of individual characteristics, training demands and timing of consumption, underscoring the importance of personalized strategies in both performance and recovery settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.